| SEC | secretin; Singapore epidemic conjunctivitis; soft elastic capsule |
|---|---|
| TES | thymic epithelial supernatant; toxic epidemic syndrome; transcutaneous electrical stimulation; trans... |
| TOES | toxic oil epidemic syndrome |
| αHBe | Antibody against Hepatitis Be Antigen |
| αHBs | Antibody against Hepatitis B surface Antigen |
| epidemic transient diaphragmatic spasm | An acute infectious disease usually occurring in epidemic form, characterised by paroxysms of pain, usually in the chest, and associated with strains of Enterovirus coxsackievirus type B. Synonym: benign dry pleurisy, Bornholm disease, Daae's disease, devil's grip, diaphragmatic pleurisy, epidemic benign dry pleurisy, epidemic diaphragmatic pleurisy, epidemic myalgia, epidemic myositis, myositis epidemica acuta, epidemic transient diaphragmatic spasm, Sylvest's disease. (05 Mar 2000) |
|---|---|
| epidemic tremor | <veterinary> A disease of very young chicks caused by a picornavirus and characterised by tremor, ataxia, somnolence, and finally death. Synonym: epidemic tremor. (05 Mar 2000) |
| epidemic typhus | <infectious disease> A severe acute disease with prolonged high fever up to 40 |
| epidemic vertigo | A paroxysmal attack of severe vertigo, not accompanied by deafness or tinnitus, which affects young to middle-aged adults, often following a non-specific upper respiratory infection; due to unilateral vestibular dysfunction. Synonym: endemic paralytic vertigo, epidemic vertigo, Gerlier's disease, kubisagari, kubisagaru, paralyzing vertigo. (05 Mar 2000) |
| epidemic vomiting | Virus caused by Norwalk virus, a 27 nm RNA virus in the family Caliciviridae frequently occurring in a group of people (e.g., in a school or small community) suddenly and without prodromal illness or malaise, is intense while it lasts, but ceases abruptly after a few hours or a day or so; symptoms are headache, abdominal pain, giddiness, and diarrhoea in most of the cases, and extreme prostration in about 75%. Synonym: epidemic nausea. (05 Mar 2000) |
| typhus, epidemic | A severe acute disease with prolonged high fever up to 40 |
| typhus, epidemic louse-borne | The classic form of typhus, caused by rickettsia prowazekii, which is transmitted from man to man by the louse pediculus humanus corporis. This disease is characterised by the sudden onset of intense headache, malaise, and generalised myalgia followed by the formation of a macular skin eruption and vascular and neurologic disturbances. (12 Dec 1998) |
| acute parenchymatous hepatitis | A lesion in which there is extensive and rapid death of parenchymal cells of the liver, sometimes with fatty degeneration of the size of the organ; the necrosis may result from fulminant viral infection or chemical poisoning; associated with jaundice. Synonym: acute parenchymatous hepatitis, Rokitansky's disease. (05 Mar 2000) |
| anicteric hepatitis | Hepatitis without jaundice. (05 Mar 2000) |
| anicteric virus hepatitis | A relatively mild hepatitis, without jaundice, due to a virus; the principal physical signs and symptoms are enlargement of the liver, lymph nodes, and often the spleen, together with headache, continuous fatigue, nausea, anorexia, sudden distaste for smoking, abdominal pains, and sometimes mild fever; labratory tests reveal evidence of hepatitis. (05 Mar 2000) |
| autoimmune hepatitis | <pathology> A type of chronic active hepatitis that results from circulating auto-antibodies and chronic inflammation of the liver. Symptoms are those of chronic active hepatitis. (27 Sep 1997) |
| vaccination, hepatitis a | When immediate protection against hepatitis a (infectious hepatitis) is needed, immunoglobulins are used. Protection is effective only if given within 2 weeks of exposure and lasts but 2-4 months. Immunoglobulins can be used to protect household contacts of someone with acute viral hepatitis and travelers to regions with poor sanitation and high hepatitis a rates, when the traveler has to depart sooner than the vaccines can take effect (about 2 weeks). Travelers can receive the immunoglobulin and vaccine simultaneously and be protected immediately and for longer term. When immediate protection is not needed, hepatitis a vaccines are considered for individuals in high-risk settings, including frequent world travelers, sexually active individuals with multiple partners, homosexual men, individuals using illicit drugs, employees of daycare centres, and certain health care workers, and sewage workers. Two hepatitis a vaccines called havrix and vaqta are commercially available in the u.s. Both are highly effective and provide protection even after only one dose. Two doses are recommended for adults and 3 doses for children (under 18 years of age) to provide prolonged protection. (12 Dec 1998) |
| vaccination, hepatitis b | Hepatits B (hep B) vaccine gives prolonged protection, but 3 shots over a half year are usually required. In the u.s., all infants receive hep b vaccine. Two vaccines (engerix-b, and recombivax-hb) are available in the us. The first dose of hep b vaccine is frequently given while the newborn is in the hospital or at the first doctor visit following birth. The second dose is given about 30 days after the initial dose. A booster dose is performed approximately six months later. Babies born to mothers testing positive for hep b receive, in addition, hbig (hep b immune globulin) for prompt protection. Older children (11-12 years) are advised to receive a hep b booster as are adults in high-risk situations including healthcare workers, dentists, intimate and household contacts of patients with chronic hep b infection, male homosexuals, individuals with multiple sexual partners, dialysis patients, iv drug users, and recipients of repeated transfusions. Health care workers accidentally exposed to materials infected with hep b (such as needle sticks), and individuals with known sexual contact with hep b patients are available in the u.s. Both are highly effective and provide protection even after only one dose. Two doses are recommended for adults and 3 doses for children (under 18 years of age) to provide prolonged protection. Vaccination, hepatitis b: hepatits b (hep b) vaccine gives prolonged protection, but 3 shots over a half year are usually required. In the u.s., all infants receive hep b vaccine. Two vaccines (engerix-b, and recombivax-hb) are available in the us. The first dose of hep b vaccine is frequently given while the newborn is in the hospital or at the first doctor visit following birth. The second dose is given about 30 days after the initial dose. A booster dose is performed approximately six months later. Babies born to mothers testing positive for hep b receive, in addition, hbig (hep b immune globulin) for prompt protection. Older children (11-12 years) are advised to receive a hep b booster as are adults in high-risk situations including healthcare workers, dentists, intimate and household contacts of patients with chronic hep b infection, male homosexuals, individuals with multiple sexual partners, dialysis patients, iv drug users, and recipients of repeated transfusions. Health care workers accidentally exposed to materials infected with hep b (such as needle sticks), and individuals with known sexual contact with hep b patients are usually given both hbig and vaccine to provide immediate and long term protection. (12 Dec 1998) |
| vaccination, infectious hepatitis | See Vaccination, hepatitis a. (12 Dec 1998) |
| vaccineation, serum hepatitis | See Vaccination, hepatitis b. (12 Dec 1998) |